ZC3H12C Inhibitors
Chemical inhibitors of ZC3H12C can play a significant role in modulating its function by targeting various signaling pathways that ZC3H12C is involved in. LY294002 and Wortmannin are both inhibitors of phosphoinositide 3-kinases (PI3K). These inhibitors can disrupt ZC3H12C activity by preventing PI3K from phosphorylating downstream targets, which are crucial for the signaling pathways that ZC3H12C is part of. Similarly, Rapamycin inhibits the mammalian target of rapamycin (mTOR), a key regulator in cell growth and metabolism, which can lead to a decrease in the functional activity of ZC3H12C. Furthermore, PP2, acting as a selective inhibitor of Src family tyrosine kinases, can lead to reduced phosphorylation of downstream targets, negatively impacting ZC3H12C function.
Compounds like PD98059 and U0126 are selective inhibitors of MEK, which is part of the MAPK/ERK pathway, a pathway that ZC3H12C regulates. Inhibition of MEK by these compounds can hinder the phosphorylation and activation of ERK, which is linked to the regulation of immune and inflammatory responses where ZC3H12C is implicated. SB203580 and SP600125 target the p38 MAP kinase and c-Jun N-terminal kinase (JNK) respectively, which are important in managing inflammatory responses and stress signals. Inhibition of these kinases can lead to the functional inhibition of ZC3H12C by interfering with the pathways it controls. Additionally, PKC inhibitors such as GF109203X, Go6983, and Ro-31-8220 can result in the functional inhibition of ZC3H12C by disrupting signaling mechanisms that involve PKC isoforms, which are potentially connected to the regulatory functions of ZC3H12C.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a potent inhibitor of phosphoinositide 3-kinases (PI3K), which are involved in various signaling pathways. ZC3H12C is known to interact with components of the PI3K pathway; thus, inhibition of PI3K by LY294002 can reduce downstream signaling that may be required for the functional activity of ZC3H12C. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of mitogen-activated protein kinase kinase (MEK), a kinase upstream of the extracellular signal-regulated kinases (ERK) pathway. Since ZC3H12C has been implicated in the regulation of MAPK/ERK pathway components, inhibition by PD98059 can disrupt ERK activation, indirectly inhibiting ZC3H12C activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 specifically inhibits p38 MAP kinase, which is involved in inflammatory responses and cellular stress signals. ZC3H12C plays a role in immune regulation and could be dependent on p38 MAPK signaling. Inhibition of this kinase by SB203580 could therefore lead to the functional inhibition of ZC3H12C. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which modulates inflammatory responses. ZC3H12C is suggested to be involved in inflammatory pathways, and inhibition of JNK by SP600125 can suppress the activity of transcription factors that are potential regulators of ZC3H12C, leading to its functional inhibition. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK, which is part of the MAPK/ERK pathway. By inhibiting MEK, U0126 can hinder the phosphorylation and activation of ERK, which is linked to the regulation of immune and inflammatory responses that ZC3H12C may be a part of. Thus, U0126 can indirectly inhibit ZC3H12C by impeding its regulatory pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent and irreversible inhibitor of PI3K. Given ZC3H12C's association with signaling pathways involving PI3K, the inhibition of this kinase by Wortmannin can disrupt the activity of downstream effectors that are crucial for ZC3H12C's role in cellular processes, leading to its functional inhibition. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an inhibitor of the mammalian target of rapamycin (mTOR), which is a central regulator of cell growth and metabolism. ZC3H12C may be involved in processes regulated by mTOR, and inhibition of mTOR by Rapamycin could lead to a decrease in ZC3H12C activity as part of the broader suppression of cell signaling networks. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is a selective inhibitor of Src family tyrosine kinases. As ZC3H12C can be involved in signaling pathways regulated by Src kinases, inhibition by PP2 can lead to reduced phosphorylation of downstream targets, negatively impacting the functional activity of ZC3H12C. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
GF109203X, also known as Bisindolylmaleimide I, is a specific inhibitor of protein kinase C (PKC). As PKC is implicated in a variety of cellular functions that ZC3H12C could regulate or be affected by, inhibition of PKC by GF109203X can result in the functional inhibition of ZC3H12C by disrupting its signaling context. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Go6983 is a pan-PKC inhibitor, which inhibits multiple isoforms of PKC. Given that ZC3H12C may act within or be modulated by PKC-dependent pathways, inhibition by Go6983 can impair the cellular functions in which ZC3H12C is involved, leading to its functional inhibition. | ||||||